Duilio Brugnoni
Overview
Explore the profile of Duilio Brugnoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Linko S, Boursier G, Bernabeu-Andreu F, Dzneladze N, Vanstapel F, Brguljan P, et al.
Clin Chem Lab Med
. 2025 Jan;
PMID: 39752732
The EN ISO 15189:2022 standard, titled "Medical laboratories - Requirements for quality and competence," is a significant update to the regulations for medical laboratories. The revised standard was published on...
2.
Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, et al.
Brain
. 2024 Dec;
148(2):408-415.
PMID: 39679606
Plasma phosphorylated-tau217 (p-tau217) has been shown to be one of the most accurate diagnostic markers for Alzheimer's disease. No studies have compared the clinical performance of p-tau217 as assessed by...
3.
Caravaggi E, Serana F, Carini M, Ferrari F, Tregambe D, Micheletti M, et al.
Ann Clin Biochem
. 2024 Oct;
:45632241295694.
PMID: 39415315
Introduction: Haemophagocytic lymphohistiocytosis (HLH) is a rare and serious immunological syndrome that involves a strong activation of cytotoxic T lymphocytes and macrophages. HLH determines a cytokine-mediated tissue injury with a...
4.
Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA
Quaresima V, Pilotto A, Trasciatti C, Tolassi C, Parigi M, Bertoli D, et al.
Neurobiol Aging
. 2024 Aug;
143:30-40.
PMID: 39208716
Aim of the project was to evaluate the technical and clinical validity of plasma Lumipulse p-tau, Aβ42 and Aβ40 species and their correlation with CSF core Alzheimer's Disease (AD) markers;...
5.
Radici V, Giagulli C, Buttini E, Farina M, Polverelli N, Brugnoni D, et al.
Front Transplant
. 2024 Jul;
2:1238494.
PMID: 38993894
Background: The COVID-19 pandemic has had a significant impact on the management and care of onco-hematological patients, particularly those with lymphoproliferative disorders who are at higher risk for COVID-19 associated...
6.
Brguljan P, Thelen M, Bernabeu-Andreu F, Kroupis C, Boursier G, Vukasovic I, et al.
Adv Lab Med
. 2024 Jun;
5(2):109-114.
PMID: 38939203
No abstract available.
7.
Brguljan P, Thelen M, Bernabeu-Andreu F, Kroupis C, Boursier G, Vukasovic I, et al.
Adv Lab Med
. 2024 Jun;
5(2):103-108.
PMID: 38939196
Many aspects of the activity of a medical laboratory have to be documented so as to facilitate the maintenance of the ongoing quality of service. As a consequence, many documents,...
8.
Pilotto A, Quaresima V, Trasciatti C, Tolassi C, Bertoli D, Mordenti C, et al.
medRxiv
. 2024 May;
PMID: 38746261
Background: Plasma phosphorylated-tau217 (p-tau217) has been shown to be one of the most accurate diagnostic markers for Alzheimer's disease (AD). No studies have compared the clinical performance of p-tau217 as...
9.
Delmonte O, Oguz C, Dobbs K, Myint-Hpu K, Palterer B, Abers M, et al.
J Allergy Clin Immunol
. 2023 Dec;
153(6):1655-1667.
PMID: 38154666
Background: Functional T-cell responses are essential for virus clearance and long-term protection after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, whereas certain clinical factors, such as older age and...
10.
Giupponi C, Bertoli D, Borlenghi E, Cattaneo C, Zollner T, Masina L, et al.
Blood Cancer J
. 2023 Dec;
13(1):194.
PMID: 38129393
No abstract available.